Key Data Points

Primary metrics and data points about Gilead Sciences.
Current Price: $87.25
Prev Close: $85.26
Open: $84.20
Bid: $87.10
Ask: $87.25
Day's Range: $84.10 - $88.48
52wk Range: $81.89 - $123.37
Volume: 14,312,202
Avg Vol 13,396,908
Market Cap: $125.74B
P/E (ttm): 6.76
EPS (ttm): $12.61
Div & Yield: $1.72 (2.0%)

Business Summary

Industry, sector and description for Gilead Sciences.

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers

Stock Charting

GILD vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Gilead Sciences.
CAPS Rating 5 out of 5
 
3490 Outperform
83 Underperform
CAPS All Stars
 
682 Outperform
16 Underperform

Powered by Motley Fool CAPS


More Details about Gilead Sciences

Primary metrics and data points about Gilead Sciences.